Researchers developed bioengineered lymphatic tissue that replaced missing lymph nodes in mice, with potential to treat ...

What Is Marginal Zone Lymphoma? Marginal zone lymphoma (MZL) isn’t one disease. It’s a group of rare, slow-growing blood cancers. They’re known as non-Hodgkin lymphomas because they start in your ...

Rice University's SynthX Center, directed by Han Xiao, has received an up to five-year, $18 million award from the Advanced ...

Combined-Modality Therapy for Clinical Stage I or II Hodgkin's Lymphoma: Long-Term Results of the European Organisation for Research and Treatment of Cancer H7 Randomized Controlled Trials A total of ...

Weill Cornell Medicine has received a $5.2 million, initial two-year award from the Advanced Research Projects Agency for Health (ARPA-H) Lymphatic Imaging, Genomics, and pHenotyping Technologies ...

REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for ...

India, Jan. 24 -- Monash University researchers are part of a US-led team working together to develop the first imaging ...

It's assumed that as we get older our health will gradually deteriorate. Our bodies age, wrinkles form, metabolism slows, and our immune system weakens. But how much of what we consider to simply be ...

Cancerous and non-cancerous blood disorders that affect the development of red blood cells can be cured through allogeneic hematopoietic stem cell transplantation (allo-HSCT). The efficacy of the ...